DM loss in k haplotype mice reveals isotype-specific chaperone requirements

Journal of Immunology

Volumn 170, Issue 7, 2003, Pages 3751-3761

  Koonce, Chad H ^a   Wutz, Gordana ^a   Robertson, Elizabeth J ^a   Vogt, Anne B ^b   Kropshofer, Harald ^b   Bikoff, Elizabeth K ^a  

^a HARVARD UNIVERSITY   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; PROTEIN DM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CELL MUTANT; CONTROLLED STUDY; ENDOSOME; GENE LOCUS; GENE MUTATION; HAPLOTYPE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION;

EID: 0037378896     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.7.3751     Document Type: Article

References (91)

1. Goldrath, A. W., and M. J. Bevan. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature 402:255.
2. Nelson, C. A., and D. H. Fremont. 1999. Structural principles of MHC class II antigen presentation. Rev. Immunonogenet. 1:47.
3. Wolf, P. R., and H. L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell. Dev. Biol. 11:267.
4. Busch, R., and E. D. Mellins. 1996. Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr. Opin. Immunol. 8:51.
5. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802.
6. Kropshofer, H., A. B. Vogt, G. Moldenhauer, J. Hammer, J. S. Blum, and G. J. Hammerling. 1996. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15:6144.
7. Denzin, L. K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153.
8. Kropshofer, H., S. O. Arndt, G. Moldenhauer, G. J. Hammerling, and A. B. Vogt. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6:293.
9. Chicz, R. M., R. G. Urban, W. S. Lane, J. C. Gorga, L. J. Stern, D. A. A. Vignali, and J. L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size. Nature 358:764.
10. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
11. Bijlmakers, M. J. E., P. Benaroch, and H. L. Ploegh. 1994. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med. 180:623.
12. Romagnoli, P., and R. N. Germain. 1994. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex II folding, transport, and peptide occupancy. J. Exp. Med. 180:1107.
13. Malcherek, G., V. Gnau, G. Jung, H. G. Rammensee, and A. Melms. 1995. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J. Exp. Med. 181:527.
14. Bikoff, E. K., R. N. Germain, and E. J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301.
15. Villadangos, J. A., R. J. Riese, C. Peters, H. A. Chapman, and H. L. Ploegh. 1997. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186:549.
16. Bikoff, E. K., G. Kenty, and L. van Kaer. 1998. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms. J. Immunol. 160:3101.
17. Sette, A., S. Southwood, J. Miller, and E. Appella. 1995. Binding of major histocompatibility complex class II to the invariant chain derived peptide. CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181:677.
18. Liang, M. N., C. Beeson, K. Mason, and H. M. McConnell. 1995. Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC. Int. Immunol. 7:1397.
19. Gautam, A. M., M. Yang, P. J. Milburn, R. Baker, A. Bhamagar, J. McCluskey, and T. Boston. 1997. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner. J. Immunol. 159:2782.
20. Weenink, S. M., P. J. Milburn, and A. M. Gautam. 1997. A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II molecules. Int. Immunol. 9:317.
21. Hausmann, D. H., B. Yu, S. Hausmann, and K. W. Wucherpfennig. 1999. pH-dependent peptide binding properties of the type 1 diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH. J. Exp. Med. 189:1723.
22. k class II molecules in human APC containing deleted or mutated HLA DM genes. J. Immunol. 153:5382.
23. Stebbins, C. C., G. E. Loss Jr., C. G. Elias, A. Chervonsky, and A. J. Sant. 1995. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J. Exp. Med. 181:223.
24. Stebbins, C. C., M. E. Peterson, W. M. Suh, and A. J. Sant. 1996. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. J. Immunol. 157:4892.
25. d class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines. Int. Immunol. 9:889.
26. Wolf, P. R., S. Tourne, T. Miyazaki, C. Benoist, D. Mathis, and H. L. Ploegh. 1998. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed. Eur. J. Immunol. 28:2605.
27. Nadimi, F., J. Moreno, F. Momburg, A. Heuser, S. Fuchs, L. Adorini, and G. J. Hammerling. 1991. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur. J. Immunol. 21:1255.
28. Peterson, M., and J. Miller. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357:596.
29. Momburg, F., S. Fuchs, J. Drexler, R. Busch, M. Post, G. J. Hammerling, and L. Adorini. 1993. Epitope-specific enhancement of antigen presentation by invariant chain. J. Exp. Med. 178:1453.
30. Viville, S., J. Neefjes, V. Lotteau, A. Dierich, M. Lemeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635.
31. Pinet, V., M. S. Malnati, and E. O. Long. 1994. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J. Immunol. 152:4852.
32. Tourne, S., N. Nakano, S. Viville, C. Benoist, and D. Mathis. 1995. The influence of invariant chain on the positive selection of single T cell re-ceptor specificities. Eur. J. Immunol. 25:1851.
33. Lindner, R., and E. R. Unanue. 1996. Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 15:6910.
34. Nanda, N. K., and A. J. Sant. 2000. DM determines the cryptic and immunodominant fate of T cell epitopes. J. Exp. Med. 192:781.
35. Sekaly, R. P., S. Jacobson, J. R. Richert, C. Tonnelle, H. F. McFarland, and E. O. Long. 1988. Antigen presentation to HLA class II-restricted measles virus-specific T cell clone can occur in the absence of the invariant chain. Proc. Natl. Acad. Sci. USA 85:1209.
36. Villadangos, J. A., C. Driessen, G. P. Shi, H. A. Chapman, and H. L. Ploegh. 2000. Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM. EMBO J. 19:882.
37. Kozono, H., J. White, J. Clements, P. Marrack, and J. Kappler. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369:151.
38. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.
39. + T cells in the periphery and secondary proliferative responses elicited upon peptide challenge. J. Immunol. 163:232.
40. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules antigen presentation, and T cell repertoire selection. Cell 84:543.
41. Miyazaki, T., P. Wolf, S. Tourne, C. Waltziner, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531.
42. Fung-Leung, W. P., C. D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P. A. Peterson, S. R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278.
43. + T cell maturation in BALB/c mice. J. Immunol. 166:5087.
44. Yagi, T., T. Tokunaga, Y. Furuta, S. Nada, M. Yoshida, T. Tsukada, Y. Saga, N. Takeda, Y. Ikawa, and S. Aizawa. 1993. A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214:70.
45. Adorini, L., J. C. Guery, S. Fuchs, S. Ortiz-Navarrete, G. J. Hammerling, and F. Momburg. 1993. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells. J. Immunol. 151:3576.
46. Haskins, K., C. Hannum, J. White, N. Roehn, R. Kubo, J. Kappler, and P. M. Marrack. 1984. The antigen-specific major histocompatibility complex-restricted receptor on T cells: an antibody to a receptor allotype. J. Exp. Med. 160:452.
47. Allen, P. M., and E. R. Unanue. 1984. Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J. Immunol. 132:1077.
48. Kropshofer, H., A. B. Vogt, L. J. Stern, and G. J. Hammerling. 1995. Self release of CLIP in peptide loading of HLA-DR molecules. Science 270:1357.
49. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
50. Nakagawa, T. Y. and A. Y. Rudensky. 1999. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 172:121.
51. Villadangos, J. A., and H. L. Ploegh. 2000. Proteolysis in MHC class II antigen presentation: who's in charge? Immunity 12:233.
52. Germain, R. N., and A. G. Rinker, Jr. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363:725.
53. Sadegh-Nasseri, S., L. J. Stern, D. C. Wiley, and R. N. Germain. 1994. MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370:647.
54. Rabinowitz, J. D., M. Vrljic, P. M. Kasson, M. N. Liang, R. Busch, J. J. Boniface, M. M. Davis, and H. M. McConnell. 1998. Formation of a highly peptide-receptive state of class II MHC. Immunity 9:699.
55. Natarajan, S. K., M. Assadi, and S. Sadegh-Nasseri. 1999. Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. J. Immunol. 162:4030.
56. Busch, R., G. Strang, K. Howland, and J. B. Rothbard. 1990. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int. Immunol. 2:443.
57. Buus, S., A. Sette, S. M. Colon, C. Miles, and H. M. Grey. 1987. The relationship between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235:1353.
58. Rudensky, A. Y., P. Preston-Hurlburt, S. C. Hong, A. Barlow, and C. A. Janeway, Jr. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622.
59. d. Science 256:1817.
60. Marrack, P., L. Ignatowicz, J. W. Kappler, J. Boymel, and J. H. Freed. 1993. Comparison of peptides bound to spleen and thymus class II. J. Exp. Med. 178:2173.
61. Kropshofer, H., G. J. Hammerling, and A. B. Vogt. 1999. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol. Rev. 172:267.
62. Vogt, A. B., L. J. Stern, D. Amshoff, B. Dobberstein, G. J. Hammerling, and H. Kropshofer. 1995. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol. 155:4757.
63. Jasanoff, A., S. Song, A. R. Dinner, G. Wagner, and D. C. Wiley. 1999. One of two unstructured domains of Ii becomes ordered in complexes with MHC class II molecules. Immunity 10:761.
64. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
65. Stumptner, P., and P. Benaroch. 1997. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region. EMBO J. 16:5807.
66. Thayer, W. P., L. Ignatowicz, D. A. Weber, and P. E. Jensen. 1999. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules. J. Immunol. 162:1502.
67. Gugasyan, R., C. Velazquez, I. Vidavsky, B. M. Deck, K. van der Drift, M. L. Gross, and E. R. Unanue. 2000. Independent selection by I-A(k) molecules of two epitopes found in tandem in an extended polypeptide antigen. J. Immunol. 165:3206.
68. d-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8:319.
69. Liu, X., S. Dai, F. Crawford, R. Fruge, F. Crawford, R. Fruge, P. Marrack, and J. Kappler. 2002. Alternative interactions define the binding of peptides to the MHC molecule IA(b). Proc. Natl. Acad. Sci. USA 99:8820.
70. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1994. Peptide determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371:250.
71. Ceman, S., S. Wu, T. S. Jardetzky, and A. J. Sant. 1998. Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal. J. Exp. Med. 188:2139.
72. Arneson, L. S., J. F. Katz, M. Liu, and A. J. Sant. 2001. Hydrogen bond integrity between MHC class II molecules and bound peptide determines the intracellular fate of MHC class II molecules. J. Immunol. 167:6939.
73. McNicholas, J., M. Steinmetz, T. Hunkapillar, P. Jones, and L. Hood. 1982. DNA sequence of the gene encoding the Eα Ia polypeptide of the BALB/c mouse. Science 218:1229.
74. Mathis, D. J., C. Benoist, V. Williams, M. Kanter, and H. McDevitt. 1983. The murine Eα immune response gene. Cell 32:745.
75. Sadegh-Nasseri, S., and R. N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature 353:167.
76. Wettstein, D. A., J. J. Boniface, P. A. Reay, H. Schild, and M. M. Davis. 1991. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J. Exp. Med. 174:219.
77. Reay, P. A., D. A. Wettstein, and M. M. Davis. 1992. pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J. 11:2829.
78. Altman, J. D., P. A. Reay, and M. M. Davis. 1993. Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 90:10330.
79. Boniface, J. J., D. S. Lyons, D. A. Wettstein, N. L. Allbritton, and M. M. Davis. 1996. Evidence for a conformational change in a class II major histocompatibility complex molecule occuring in the same pH range where antigen binding is enhanced. J. Exp. Med. 183:119.
80. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
81. Han, R. 1997. Impact of a truncated invariant chain on in vitro assembly of class II MHC molecules depends on the affinity of invariant chain for a given αβ dimer. Immunol. Invest. 26:421.
82. Castellino, F., R. Han, and R. N. Germain. 2001. The transmembrane segment of invariant chain mediates binding to MHC class II molecules in a CLIP-independent manner. Eur. J. Immunol. 31:841.
83. Doebele, R. C., R. Busch, H. M. Scott, A. Pashine and E. D. Mellins. 2000. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 13:517.
84. Reinherz, E. L., K. Tan, L. Tang, P. Kern, J. Liu, Y. Xiong, R. E. Hussey, A. Smolyar, B. Hare, R. Zhang, et al. 1999. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286:1913.
85. Hennecke, J., A. Carfi, and D. C. Wiley. 2000. Structure of a covalently stabilized complex of a human T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 19:5611.
86. Pu, Z., J. A. Carrero, and E. R. Unanue. 2002. Distinct recognition by two subsets of T cells of an MHC class II-peptide complex. Proc. Natl. Acad. Sci. USA 99:8844.
87. Fairchild, P. J., R. Wildgoose, E. Atherton, S. Webb, and D. C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151.
88. Lee, C., M. N. Liang, K. M. Tate, J. D. Rabinowitz, C. Beeson, P. P. Jones, and H. M. McConnell. 1998. Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft. J. Exp. Med. 187:1505.
89. Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R Prowie, D. Kioussis, and D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407.
90. Peterson, D. A., R. J. DiPaolo, O. Kanagawa, and E. R Unanue. 1999. Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity 11:453.
91. Ting, J. P. Y., and J. Trowsdale. 2002. Genetic control of MHC class II expression. Cell 109:S21.